Home » Topics » BioWorld Science

BioWorld Science
RSS

Merck & Co. patents lysine-specific demethylase 5B inhibitors

May 9, 2018

New RIP-1 inhibitors discovered at Roche, Genentech

May 9, 2018

Intravenous formulation of Akynzeo launched in the U.S.

May 9, 2018

Cellcentric divulges new KAT3 and/or CREB-binding protein inhibitors

May 9, 2018

Nektar Therapeutics initiates phase Ib trial of NKTR-358 in patients with SLE

May 9, 2018

Novartis describes novel IKACh channel blockers

May 9, 2018

Novel serine palmitoyltransferase inhibitors identified at Takeda

May 9, 2018

Durable antidepressive effect seen with ALKS-5461 in phase III trial

May 9, 2018

Dare Bioscience enters agreement with Pear Tree Pharmaceuticals to secure rights to PT-101

May 9, 2018

Valeant Pharmaceuticals International to change name to Bausch Health Companies

May 8, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...